Palmitate‐Stimulated Monocytes Induce Adhesion Molecule Expression in Endothelial Cells via IL‐1 Signaling Pathway
暂无分享,去创建一个
Akiko Hata | N. Aki | Y. Shikama | M. Funaki | S. Oyadomari | Miho Nishimura | Nanako Aki
[1] H. Joller-jemelka,et al. Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. , 2002, The Journal of clinical investigation.
[2] Han-Kyu Lee,et al. Oleate prevents palmitate-induced mitochondrial dysfunction, insulin resistance and inflammatory signaling in neuronal cells. , 2014, Biochimica et biophysica acta.
[3] L. Riva,et al. Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes/macrophages[S] , 2013, Journal of Lipid Research.
[4] B. V. Van Tassell,et al. Targeting interleukin-1 in heart disease. , 2013, Circulation.
[5] J. Rutledge,et al. Inflammasome-Mediated Secretion of IL-1β in Human Monocytes through TLR2 Activation; Modulation by Dietary Fatty Acids , 2013, The Journal of Immunology.
[6] N. Ishimaru,et al. Effects of Free Fatty Acids on Human Salivary Gland Epithelial Cells , 2013, Journal of dental research.
[7] G. Owens,et al. Genetic and Pharmacologic Disruption of Interleukin-1&bgr; Signaling Inhibits Experimental Aortic Aneurysm Formation , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[8] A. Hasty,et al. Stearic Acid Accumulation in Macrophages Induces Toll-Like Receptor 4/2-Independent Inflammation Leading to Endoplasmic Reticulum Stress–Mediated Apoptosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[9] S. Kersten,et al. Energy-sensing Factors Coactivator Peroxisome Proliferator-activated Receptor γ Coactivator 1-α (PGC-1α) and AMP-activated Protein Kinase Control Expression of Inflammatory Mediators in Liver , 2011, The Journal of Biological Chemistry.
[10] F. Civeira,et al. Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions. , 2011, Biochimica et biophysica acta.
[11] G. Zaloga,et al. Long-chain saturated fatty acids induce pro-inflammatory responses and impact endothelial cell growth. , 2010, Clinical nutrition.
[12] Marc Daigneault,et al. The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived Macrophages , 2010, PloS one.
[13] F. Geissmann,et al. Monocytes in atherosclerosis: subsets and functions , 2010, Nature Reviews Cardiology.
[14] G. Moneta,et al. Major Lipids, Apolipoproteins, and Risk of Vascular Disease , 2010 .
[15] J. Danesh,et al. Major lipids, apolipoproteins, and risk of vascular disease. , 2009, JAMA.
[16] N. Samani,et al. Saturated Fatty Acids Do Not Directly Stimulate Toll-Like Receptor Signaling , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[17] F. Kim,et al. Activation of NF-&kgr;B by Palmitate in Endothelial Cells: A Key Role for NADPH Oxidase-Derived Superoxide in Response to TLR4 Activation , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[18] G. Lacraz,et al. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat , 2009, Proceedings of the National Academy of Sciences.
[19] Walter C Willett,et al. Dietary fats and prevention of type 2 diabetes. , 2009, Progress in lipid research.
[20] B. Fielding,et al. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. , 2008, Progress in lipid research.
[21] T. Hawn,et al. Toll-Like Receptor-4 Mediates Vascular Inflammation and Insulin Resistance in Diet-Induced Obesity , 2007, Circulation research.
[22] J. Pankow,et al. Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study , 2006, Diabetologia.
[23] J. Flier,et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.
[24] P. Reaven,et al. Elevated Concentrations of Nonesterified Fatty Acids Increase Monocyte Expression of CD11b and Adhesion to Endothelial Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[25] Barbara Thorand,et al. Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[26] E. Trimble,et al. Activation of peripheral blood CD14+ monocytes occurs in diabetes. , 2005, Diabetes.
[27] F. Ohsuzu,et al. Deficiency of Interleukin-1 Receptor Antagonist Deteriorates Fatty Liver and Cholesterol Metabolism in Hypercholesterolemic Mice* , 2005, Journal of Biological Chemistry.
[28] T. Kadowaki,et al. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. , 2005, Endocrinology.
[29] A. Bonen,et al. A Novel Function for Fatty Acid Translocase (FAT)/CD36 , 2004, Journal of Biological Chemistry.
[30] N. Takahashi,et al. Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. , 2004, Atherosclerosis.
[31] H. Aburatani,et al. A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage. , 2004, Journal of atherosclerosis and thrombosis.
[32] Bing‐Bing Yang,et al. Pharmacokinetics of anakinra in subjects with different levels of renal function , 2003, Clinical pharmacology and therapeutics.
[33] E. Boerwinkle,et al. Interaction Between Soluble Thrombomodulin and Intercellular Adhesion Molecule-1 in Predicting Risk of Coronary Heart Disease , 2003, Circulation.
[34] M. Seishima,et al. Lack of Interleukin-1&bgr; Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[35] M. Babina,et al. All‐trans retinoic acid down‐regulates expression and function of β2 integrins by human monocytes: opposite effects on monocytic cell lines , 2003, European journal of immunology.
[36] T. V. van Berkel,et al. Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential , 2003, Pharmacological Reviews.
[37] W. Arend. The balance between IL-1 and IL-1Ra in disease. , 2002, Cytokine & growth factor reviews.
[38] M. Sampson,et al. Monocyte and Neutrophil Adhesion Molecule Expression During Acute Hyperglycemia and After Antioxidant Treatment in Type 2 Diabetes and Control Patients , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[39] H. Joller-jemelka,et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. , 2002, The Journal of clinical investigation.
[40] E. Boerwinkle,et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. , 1997, Circulation.
[41] A. Baron,et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. , 1997, The Journal of clinical investigation.
[42] E. Eschwège,et al. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study , 1997, Diabetologia.
[43] N. Hoogerbrugge,et al. Hypertriglyceridemia Enhances Monocyte Binding to Endothelial Cells in NIDDM , 1996, Diabetes Care.
[44] U. Ikeda,et al. Monocyte-endothelial cell interaction induces expression of adhesion molecules on human umbilical cord endothelial cells. , 1996, Cardiovascular research.
[45] P. Brandtzaeg,et al. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. , 1996, Journal of immunology.
[46] M. Alessio,et al. Synthesis, Processing, and Intracellular Transport of CD36 during Monocytic Differentiation (*) , 1996, The Journal of Biological Chemistry.
[47] D. Waters,et al. Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. , 1995, Circulation.
[48] A. Kleinfeld,et al. Unbound free fatty acid levels in human serum. , 1995, Journal of lipid research.
[49] A. Koch,et al. Intercellular adhesion molecule‐1 (ICAM‐1) expression and soluble ICAM‐1 (sICAM‐1) production by cytokine‐activated human aortic endothelial cells: a possible role for ICAM‐1 and sICAM‐1 in atherosclerotic aortic aneurysms , 1994, Clinical and experimental immunology.
[50] K. Vaddi,et al. Comparison of biological responses of human monocytes and THP‐1 cells to chemokines of the intercrine‐β family , 1994, Journal of leukocyte biology.
[51] T. Springer. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.
[52] J. Neefjes,et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. , 1992, Immunology.
[53] W. Arend,et al. IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently. , 1991, Journal of immunology.
[54] C. Dinarello,et al. Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated. , 1991, Blood.
[55] C. Avnstorp,et al. Interleukin‐1 , 1987 .